Gout Pharmacotherapies Joseph Kitzmiller MD PhD FCP 5086 Graves Hall Assistant Professor – Biological Chemistry & Pharmacology

Slides:



Advertisements
Similar presentations
GOUT Disease caused by tissue deposition of Monosodium urate crystals as a result of supersatuaration of extra cellular fluid with MSU.
Advertisements

Team Meeting Presentations
Anti-Inflammatory & Immunosuppressive Drugs 2
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen.
TXF Caveat on urate levels Serum uric acid level may be normal at the time of an acute attack. Normal level does not rule out gout. May be better.
Anti-Inflammatory Drugs. Insert Inflammation Diagram.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 44 Antiinflammatory and Antigout Drugs.
Prepared by : Tamara Odeh Diana Jawhari Supervised by : Dr. Ola Ayesh.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Gout.
GOUT. OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe treatment of acute gouty arthritis Describe.
Gout: Its not all crystal clear Robert L. Wortmann, M.D. Department of Internal Medicine The University of Oklahoma College of Medicine, Tulsa.
Reginald D Sanders, MD LSU Clinical Pharmacology Drug Therapy of Gout.
Drugs used in joint diseases
Drugs for Management of Fever & Inflammation
GOUT. Gout is a familial metabolic disease characterized by recurrent episodes of acute arthritis due to deposits of monosodium urate crystals. The metatarsophalangeal.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
GOUT. By Prof. Azza El- Medany Dr. Osama Yousf OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe.
Chapter 13 Agents Used to Treat Hyperuricemia and Gout.
GOUT. OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe treatment of acute gouty arthritis Describe.
Anti-Inflammatory Agents ESAT 4001 Pharmacology in Athletic Training.
GOUT. By Prof. Azza El- Medany Dr. Osama Yousf OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe.
GOUT. By Prof. Azza El- Medany Dr. Osama Yousf OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe.
Anti-Inflammatory & Immunosuppressive Drugs 2
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
Non Steroidal Anti Inflammatory Drugs, Nonopioid Analgesics By S.Bohlooli, PhD.
GOUT TREATMENT. Gout prevalence doubled over the last 20 yrs. Factors? - longevity - diuretic use - low dose ASA - obesity - end stage renal disease -
Musculoskeletal Medications Osteoporosis Rheumatoid Arthritis Gout Muscle Spasms.
Drug therapy of gout - overview what is gout? what happens to patients with gout & why? what drugs are available for managing gout? how are those drugs.
Propionic acid derivatives Ibuprofen, naproxen, fenoprofen, flurbiprofen, oxaprozin,→ anti-inflammatory, analgesic, and antipyretic.  These drugs are.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 6 Nonopiod (Nonnarcotic) Analgesics.
GOUT.
Drug Therapy of Gout.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
Summary Lecture Gout/Glaucoma Learning Outcomes Predict the activity of a drug based on its structure & physiochemical properties Demonstrate an understanding.
CHAPTER © 2012 The McGraw-Hill Companies, Inc. All rights reserved. 20 Nonopioid Analgesics, Nonsteroidal Antiinflammatories, and Antigout Drugs.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
Agents Used to Treat Hyperuricemia and Gout
Chapter 44 Antiinflammatory and Antigout Drugs 1 Fall 2012.
Drug Therapy of Gout. Drug therapy of gout What Is Gout?
Corticosteroids.
- nonsteroidal anti-inflammatory drugs (NSAIDs), are used to combat inflammation. - Their antiinflammatory action equals that of aspirin. - have analgesic.
NSAIDs (non steroidal anti- inflammatory drugs). THE INFLAMMATORY RESPONSE 1.The inflammatory response is a normal (desirable) defense mechanism. 2.The.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
Colchicine: Colchicine: Effective & specific gout Rx, but less favored than NSAIDs because of slow onset of action & high incidence of side effects. Effective.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
Non-steroidal anti-inflammatory drugs
ANTI-GOUT DRUGS. GOUT A familial metabolic disease characterized by recurrent episodes of acute arthritis due to deposits of monosodium urate in joints.
Drugs in gout epidemiology Male to female ration 10:1 Prevalence of hyperuricemia 5% Prevalence of gout 0.2%
Purine Degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
Gout Is recurrent inflammatory disorder characterized by
Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Gout.
Drugs in gout epidemiology Prevalence of hyperuricemia 5%
Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Drugs in gout.
GOUTY ARHTRITIS.
ليس العار في أن نسقط، ولكنّ العار ألا نستطيع النّهوض
Drug Therapy of Gout 1.
GOUT.
Antiuricaemic drugs Dr A.W Olusanya.
Lecture 9 Musculoskeletal Disorders Gout
Munir Gharaibeh, MD, PhD, MHPE The University of Jordan
Musculoskeletal Pharmacology
Gout Scott Smith PGY-1 1/11/2018.
Drugs in gout epidemiology Prevalence of hyperuricemia 5%
Drugs in gout.
Presentation transcript:

Gout Pharmacotherapies Joseph Kitzmiller MD PhD FCP 5086 Graves Hall Assistant Professor – Biological Chemistry & Pharmacology

Suggested/Optional Readings (see Resources tab for pdfs of the following suggested/optional readings) Gout Pharmacology: Katzung Chapter 36 Pages Corticosteroids: Katzung Chapter 39 Pages 2-11

Learning Objectives For the bone-homeostasis pharmacotherapies presented in this module, describe the following:  primary mechanisms of action  indications/uses  common toxicities  cross-reactions with other medications

Gout Drugs  Several medications are used to treat patients with gout. Some are used to treat acute gout and some are used to manage patients with chronic gout, preventing future gout and minimizing long-term complications of gout (joint destructions and renal damage)  GOUT: hyperuricemia → uric acid crystals In joints: uric acid crystals → pain, swelling, stiffness, deformity, and impaired movement In kidneys: uric acid crystals → renal damage & scarring, and potentially renal insufficiency and ultimately renal failure

Gout Drugs  ACUTE GOUT DRUGS  Nonsteroidal anti-inflammatory drugs (NSAIDs)  Colchicine  Corticosteroids  CHRONIC GOUT DRUGS  Uricosuric agents  Xanthine oxidase inhibitors  Colchicine*

Nonsteroidal anti-inflammatory drugs (NSAIDs) Protypical member: Ibuprofen Indication: 1 st line for acute gout Mechanism of Action: Inhibit prostaglandin synthesis & inhibit urate crystal formation Non-selective reversible inhibition of COX1 and COX2 Adverse Effects: Gastric erosions & bleeding (due to ↓ PGE2 and ↓ prostaglandin synthesis) Renal Insufficiency (due to ↓ prostaglandin synthesis) Hypersensitivity reaction (urticaria) Other NSAIDs include ketoprofen, indomethacin, ketorolac, naproxen, and meloxicam, acetaminophen Aspirin Do not use aspirin for gout → renal retention of uric acid

Corticosteroids Protypical members: SHORTER-ACTING Prednisone & Cortisone (PO); Hydrocortisol (PO, top, inj); Prednisolone & Methylprednisolone (PO, inj) LONGER-ACTING Triamcinolone, Betamethasone and Dexamethasone (PO, inj, top) Indication: Used occasionally for severe symptomatic gout Mechanism of Action: Intracellular regulation of genes → Anti-inflammation (↓ production of prostaglandins & inflammatory cells (T & B cells, macros, baso & eosinophils) Adverse Effects: Widespread Intracellular regulation of genes → catabolic/anti-anabolic effects → immunosuppressive effects → adrenal insufficiency NOTE: Long term use of corticosteroids can lead to osteoporosis.

Colchicine Indication: Used for acute gout & for patients with chronic gout taking allopurinol Route: PO or IV Mechanism of Action: Binds intracellular tubulin→polymerizes microtubules→inhibits leukocyte migration & phagocytosis also inhibits formation of leukocyte B4 Adverse Effects: diarrhea, nausea & vomiting, abdominal pain, hepatic necrosis, acute renal failure, DIC, seizures, peripheral neuritis, myopathy Long-term use Adverse Effects: Bone marrow suppression agranulocytosis and suppression of hair follicle growth (alopecia)

Uricosuric Agents Protypical members: Probenecid & Sulfinpyrazone Indication: Used for patients with chronic gout Mechanism of Action: Inhibits uric acid reabsorption in kidneys → accelerated excretion of urate Adverse Effects: Formation of uric acid renal stones GI irritation Inhibits renal excretion of penicillins, indomethacin & sulfonylureas

Xanthine oxidase inhibitors Protypical member: Allopurinol (purine) Febuxostat (non-purine) Rasburicase & Pegloticase (recombinant of urate oxidase) Indication: Chronic gout: allopurinol is standard-of-care between episodes of gout Mechanism of Action: Inhibit production of uric acid by inhibiting xanthine oxidase Adverse Effects: Allergic skin reaction. Allopurinol by itself can precipitate acute gouty arthritis so typically given along with colchicine*. Important Drug Interactions: Mercaptopurine, azathioprine & theophylline doses typically need ↓75%

SUMMARY: Gout Drugs  ACUTE GOUT DRUGS  Nonsteroidal anti-inflammatory drugs (NSAIDs)  Colchicine  Corticosteroids  CHRONIC GOUT DRUGS  Uricosuric agents  Xanthine oxidase inhibitors  Colchicine*